Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Mimedx Group, Inc. (MDXG)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Mimedx Group, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1376339.
Total stock buying since 2015: $4,006,980.
Total stock sales since 2015: $12,272,311.
Total stock option exercises since 2015: $1,157,654.
Table 3. Detailed insider trading at Mimedx Group, Inc. (MDXG)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-11-06 | Maersk-moller Kimberly (Chief Commercial Officer) | Sale | 58,300 | 7.42 | 432,352 |
| 2025-05-02 | Capper Joseph H (Chief Executive Officer) | Buy | 200,000 | 6.34 | 1,268,000 |
| 2025-03-17 | Maersk-moller Kimberly (Chief Commercial Officer) | Sale | 1,759 | 8.04 | 14,142 |
| 2025-03-13 | Maersk-moller Kimberly (Chief Commercial Officer) | Sale | 4,106 | 7.89 | 32,396 |
| 2025-03-13 | Hulse William Frank Iv (General Counsel and CAO) | Sale | 54,596 | 7.89 | 430,762 |
| 2025-03-10 | Hulse William Frank Iv (General Counsel and CAO) | Sale | 81,446 | 7.80 | 635,278 |
| 2025-02-28 | Maersk-moller Kimberly (Chief Commercial Officer) | Sale | 2,111 | 8.40 | 17,742 |
| 2024-03-13 | Hulse William Frank Iv (General Counsel and CAO) | Sale | 20,381 | 7.95 | 162,028 |
| 2024-02-20 | Whitlow Ricci S (Chief Operating Officer) | Sale | 15,271 | 8.01 | 122,351 |
| 2024-02-16 | Whitlow Ricci S (Chief Operating Officer) | Sale | 15,493 | 8.07 | 125,074 |
| 2024-02-15 | Whitlow Ricci S (Chief Operating Officer) | Sale | 15,198 | 8.06 | 122,495 |
| 2024-02-14 | Whitlow Ricci S (Chief Operating Officer) | Sale | 15,845 | 8.03 | 127,267 |
| 2023-11-21 | Doug Rice (Chief Financial Officer) | Buy | 5,000 | 7.16 | 35,785 |
| 2023-06-23 | Capper Joseph H (Chief Executive Officer) | Buy | 42,025 | 6.50 | 273,330 |
| 2023-06-22 | Capper Joseph H (Chief Executive Officer) | Buy | 57,975 | 6.33 | 367,097 |
| 2023-05-16 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 10,365 | 5.95 | 61,630 |
| 2023-05-15 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 3,607 | 6.15 | 22,172 |
| 2023-05-10 | Phelan William Lawrence (Chief Accounting Officer) | Sale | 1,595 | 5.93 | 9,451 |
| 2023-05-10 | Hulse William Frank Iv (General Counsel and CAO) | Sale | 5,870 | 5.93 | 34,785 |
| 2023-05-10 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 5,869 | 5.93 | 34,779 |
| 2023-05-10 | Carlson Peter M (Chief Financial Officer) | Sale | 5,976 | 5.93 | 35,413 |
| 2023-05-04 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 51,756 | 5.34 | 276,480 |
| 2023-05-02 | Phelan William Lawrence (Chief Accounting Officer) | Sale | 5,200 | 3.80 | 19,739 |
| 2023-04-25 | Phelan William Lawrence (Chief Accounting Officer) | Sale | 1,628 | 3.74 | 6,095 |
| 2023-04-25 | Hulse William Frank Iv (General Counsel and CAO) | Sale | 5,988 | 3.74 | 22,419 |
| 2023-04-25 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 5,987 | 3.74 | 22,415 |
| 2023-04-25 | Carlson Peter M (Chief Financial Officer) | Sale | 6,094 | 3.74 | 22,815 |
| 2023-04-11 | Phelan William Lawrence (Chief Accounting Officer) | Sale | 1,632 | 3.31 | 5,401 |
| 2023-04-11 | Hulse William Frank Iv (General Counsel and CAO) | Sale | 5,995 | 3.31 | 19,843 |
| 2023-04-11 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 5,996 | 3.31 | 19,846 |
| 2023-04-11 | Carlson Peter M (Chief Financial Officer) | Sale | 6,100 | 3.31 | 20,191 |
| 2023-03-07 | Phelan William Lawrence (Chief Accounting Officer) | Sale | 3,396 | 4.25 | 14,416 |
| 2023-03-07 | Hulse William Frank Iv (General Counsel and CAO) | Sale | 11,308 | 4.25 | 48,002 |
| 2023-03-07 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 12,355 | 4.25 | 52,446 |
| 2023-03-07 | Carlson Peter M (Chief Financial Officer) | Sale | 12,056 | 4.25 | 51,177 |
| 2023-02-23 | Hulse William Frank Iv (General Counsel and CAO) | Sale | 15,555 | 4.53 | 70,479 |
| 2023-02-23 | Carlson Peter M (Chief Financial Officer) | Sale | 19,000 | 4.50 | 85,424 |
| 2022-12-22 | Carlson Peter M (Chief Financial Officer) | Sale | 4,992 | 2.81 | 14,052 |
| 2022-09-13 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 8,329 | 3.46 | 28,785 |
| 2022-09-12 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 19,000 | 3.44 | 65,284 |
| 2022-08-12 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 8,503 | 4.04 | 34,343 |
| 2022-08-09 | Kashyap Rohit (President, WC & Surgical) | Sale | 12,343 | 4.21 | 51,939 |
| 2022-08-04 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 19,500 | 3.62 | 70,590 |
| 2022-06-28 | Stein Robert Benjamin (President, Regenerative Med.) | Sale | 14,600 | 3.47 | 50,662 |
| 2022-06-09 | Wright Timothy R (Chief Executive Officer) | Sale | 112,000 | 3.75 | 420,000 |
| 2022-05-09 | Graves Mark (SVP & Chief Compliance Officer) | Sale | 3,891 | 3.50 | 13,622 |
| 2022-05-06 | Phelan William Lawrence (Chief Accounting Officer) | Sale | 5,750 | 3.81 | 21,907 |
| 2022-05-02 | Turner Scott M (SVP, Operations & Procurement) | Sale | 5,260 | 4.00 | 21,045 |
| 2022-03-08 | Phelan William Lawrence (Chief Accounting Officer) | Sale | 3,268 | 4.86 | 15,879 |
| 2022-03-08 | Graves Mark (SVP & Chief Compliance Officer) | Sale | 3,234 | 4.86 | 15,714 |
| 2022-03-08 | Hulse William Frank Iv (General Counsel) | Sale | 9,990 | 4.86 | 48,541 |
| 2022-03-08 | Turner Scott M (SVP, Operations & Procurement) | Sale | 4,155 | 4.86 | 20,189 |
| 2022-03-08 | Stein Robert Benjamin (EVP, Research and Development) | Sale | 11,672 | 4.86 | 56,714 |
| 2022-03-08 | Kashyap Rohit (EVP & Chief Commercial Officer) | Sale | 8,770 | 4.86 | 42,613 |
| 2022-03-08 | Carlson Peter M (Chief Financial Officer) | Sale | 10,743 | 4.86 | 52,200 |
| 2022-03-08 | Wright Timothy R (Chief Executive Officer) | Sale | 45,611 | 4.86 | 221,623 |
| 2022-02-25 | Carlson Peter M (Chief Financial Officer) | Sale | 17,400 | 4.83 | 84,076 |
| 2022-02-23 | Turner Scott M (SVP, Operations & Procurement) | Sale | 5,738 | 4.50 | 25,821 |
| 2022-02-23 | Wright Timothy R (Chief Executive Officer) | Sale | 61,000 | 4.31 | 263,093 |
| 2021-08-16 | Stein Robert Benjamin (EVP, Research and Development) | Sale | 9,362 | 11.85 | 110,967 |
| 2020-01-22 | Koob Charles E | Option Ex | 15,000 | 1.20 | 18,000 |
| 2019-06-20 | Bleser Joseph G | Option Ex | 50,000 | .70 | 35,000 |
| 2019-06-07 | Hack Bruce | Option Ex | 50,000 | .76 | 38,000 |
| 2019-06-07 | Dewberry J Terry | Option Ex | 50,000 | .70 | 35,000 |
| 2019-01-23 | Okumus Ahmet H | Sale | 1,531,700 | .93 | 1,421,417 |
| 2019-01-22 | Okumus Ahmet H | Sale | 460,000 | .96 | 441,600 |
| 2018-02-27 | Taylor William Charles (President and COO) | Option Ex | 20,000 | 1.65 | 33,000 |
| 2017-06-14 | Taylor William Charles (President and COO) | Sale | 80,000 | 14.52 | 1,161,280 |
| 2017-06-14 | Taylor William Charles (President and COO) | Option Ex | 13,812 | 7.24 | 99,998 |
| 2017-05-25 | Taylor William Charles (President and COO) | Sale | 26,571 | 13.73 | 364,952 |
| 2017-05-10 | Taylor William Charles (President and COO) | Option Ex | 19,723 | 5.07 | 99,995 |
| 2017-04-27 | Taylor William Charles (President and COO) | Sale | 26,000 | 11.40 | 296,504 |
| 2017-03-13 | Koob Charles E | Sale | 50,486 | 8.50 | 429,131 |
| 2017-03-06 | Taylor William Charles (President and COO) | Sale | 26,000 | 8.18 | 212,783 |
| 2016-09-06 | Taylor William Charles (President and COO) | Sale | 20,400 | 7.55 | 154,020 |
| 2016-08-01 | Taylor William Charles (President and COO) | Sale | 25,000 | 7.55 | 188,750 |
| 2016-07-29 | Taylor William Charles (President and COO) | Sale | 350 | 7.50 | 2,625 |
| 2016-07-28 | Taylor William Charles (President and COO) | Sale | 3,762 | 7.53 | 28,327 |
| 2016-06-16 | Taylor William Charles (President and COO) | Sale | 24,333 | 7.52 | 183,008 |
| 2016-05-20 | Petit Parker H (Chairman & CEO) | Buy | 20,000 | 6.99 | 139,800 |
| 2016-05-17 | Petit Parker H (Chairman & CEO) | Buy | 30,000 | 6.82 | 204,600 |
| 2016-05-13 | Petit Parker H (Chairman & CEO) | Buy | 40,000 | 6.75 | 270,000 |
| 2016-05-12 | Petit Parker H (Chairman & CEO) | Buy | 50,000 | 6.74 | 337,000 |
| 2015-11-13 | Evans Charles Robert | Buy | 10,000 | 7.84 | 78,390 |
| 2015-11-10 | Petit Parker H (Chairman & CEO) | Buy | 131,925 | 7.58 | 1,000,123 |
| 2015-10-30 | Haden Alexandra O (General Counsel & Secretary) | Buy | 4,150 | 7.92 | 32,855 |
| 2015-10-30 | Taylor William Charles (President and COO) | Option Ex | 40,606 | 1.65 | 66,999 |
| 2015-08-04 | Petit Parker H (Chairman & CEO) | Option Ex | 157,235 | 1.41 | 221,229 |
| 2015-05-28 | Papasan Larry W | Sale | 5,958 | 10.09 | 60,110 |
| 2015-05-19 | Taylor William Charles (President and COO) | Option Ex | 100,000 | 1.45 | 145,000 |
| 2015-05-18 | Taylor William Charles (President and COO) | Sale | 120,526 | 10.01 | 1,205,983 |
| 2015-05-15 | Taylor William Charles (President and COO) | Sale | 29,474 | 10.00 | 294,857 |
| 2015-02-23 | Petit Parker H (Chairman & CEO) | Option Ex | 153,571 | .73 | 112,106 |
| 2015-02-20 | Petit Parker H (Chairman & CEO) | Option Ex | 98,484 | 1.82 | 179,240 |
| 2015-02-18 | Mccaw Roberta L (General Counsel and Secretary) | Sale | 100,000 | 9.00 | 900,000 |
| 2015-01-05 | Taylor William Charles (President and COO) | Option Ex | 57,432 | 1.29 | 74,087 |
Insider trading activities including stock purchases, stock sales, and option exercises
of MDXG listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Mimedx Group, Inc. (symbol MDXG,
CIK number 1376339) see
the Securities and Exchange Commission (SEC) website.